Know Cancer

or
forgot password
  • cancer clinical trials in new haven, CT

  • Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
    Yale University
    New Haven, Connecticut 06520
    Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
    Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
    Yale University
    New Haven, Connecticut 06520
    Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage IV Childhood Hodgkin Lymphoma
    Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
    Yale University
    New Haven, Connecticut 06520
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Metastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage IV Adult Soft Tissue Sarcoma
    Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
    Yale University
    New Haven, Connecticut 06520
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Endometrial Effects of Metformin Action in Women With Polycystic Ovarian Syndrome (PCOS)
    Yale-New Haven Hospital Women's Center
    New Haven, Connecticut 06520-8063
    Polycystic Ovarian Syndrome
    Trial of BIBW 2992 (Afatinib) + Cetuximab in Non-Small Cell Lung Cancer
    1200.71.1003 Boehringer Ingelheim Investigational Site
    New Haven, Connecticut
    Carcinoma, Non-Small-Cell Lung
    Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma
    Yale University
    New Haven, Connecticut 06520
    Childhood Infratentorial Ependymoma, Childhood Supratentorial Ependymoma, Newly Diagnosed Childhood Ependymoma
    A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
    Yale University
    New Haven, Connecticut 06520
    Breast Cancer
    Women With Cancer: An Exercise Study to Promote Health
    Yale University
    New Haven, Connecticut 06520
    Bone Loss, Cancer
    Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Peripheral T-cell Lymphoma
    Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Breast Cancer
    Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
    Yale University
    New Haven, Connecticut 06520
    Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma
    Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Breast Cancer, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Fulvestrant With or Without Bortezomib in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
    Yale University
    New Haven, Connecticut 06520
    Estrogen Receptor-positive Breast Cancer, Stage III Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Leukemia
    Neoadjuvant Therapy for Ovarian Cancer
    Yale University
    New Haven, Connecticut 06520
    Epithelial Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer
    Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia
    Yale University
    New Haven, Connecticut 06520
    Childhood Hepatoblastoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Malignant Germ Cell Tumor, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Neuroblastoma, Recurrent Osteosarcoma, Recurrent Wilms Tumor and Other Childhood Kidney Tumors
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Yale University
    New Haven, Connecticut 06520
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Ovarian Cancer
    Low-dose (12 Gy) TSEBT+Vorinostat Versus Low-dose TSEBT Monotherapy in Mycosis Fungoides
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Cutaneous Lymphoma, Cutaneous T-cell Lymphoma
    Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia
    Yale University
    New Haven, Connecticut 06520
    B-cell Childhood Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
    Yale University
    New Haven, Connecticut 06520
    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Stage IB Esophageal Cancer, Stage IIA Esophageal Cancer, Stage IIB Esophageal Cancer, Stage IIIA Esophageal Cancer, Stage IIIB Esophageal Cancer
    Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
    Yale University
    New Haven, Connecticut 06520
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Mixed Childhood Rhabdomyosarcoma, Pleomorphic Childhood Rhabdomyosarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma
    Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma
    Yale University
    New Haven, Connecticut 06520
    Adult Supratentorial Primitive Neuroectodermal Tumor (PNET), Childhood Supratentorial Primitive Neuroectodermal Tumor, Ewing Sarcoma of Bone, Extraosseous Ewing Sarcoma, Extraosseous Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Peripheral Primitive Neuroectodermal Tumor of the Kidney, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma
    Yale University
    New Haven, Connecticut 06520
    Childhood High-grade Cerebellar Astrocytoma, Childhood High-grade Cerebral Astrocytoma, Childhood Spinal Cord Neoplasm, Untreated Childhood Brain Stem Glioma, Untreated Childhood Cerebral Astrocytoma
    Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Myelodysplastic Syndromes, MDS, RAEB, Chronic Myelomonocytic Leukemia
    BATTLE-2 Program: A Biomarker-Integrated Targeted Therapy Study
    Yale Universtiy
    New Haven, Connecticut 06520
    Lung Cancer
    An Intervention to Improve Outcomes in Patients With Advanced Cancer
    Yale New Haven Hospital/Smilow Cancer Hospital
    New Haven, Connecticut 06510
    Cancer
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Yale University
    New Haven, Connecticut 06520
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Yale University
    New Haven, Connecticut 06520
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
    The Urology Center, PC
    New Haven, Connecticut 06511
    Advanced Prostate Cancer, Prostatic Neoplasms
    Pasireotide (SOM230) With or Without Everolimus in Treating Patients With Hormone Resistant, Chemotherapy Naive Prostate Cancer
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Castrate Resistant Prostate Cancer, Chemotherapy Naive Prostate Cancer, Prostate Cancer
    Treating Low-Income Smokers in the Hospital Emergency Department
    Yale University
    New Haven, Connecticut 06520
    Tobacco Use Cessation, Smoking Cessation, Smoking, Tobacco Use Disorder
    Study of Ombrabulin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Treated With Carboplatin/Paclitaxel
    Investigational Site Number 840001
    New Haven, Connecticut 06510
    Ovarian Cancer Recurrent
    PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer
    A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
    Yale New Haven Hospital
    New Haven, Connecticut 06520
    Hematological Malignancies, Certain Lysosomal Storage and Peroxisomal Enzyme Deficiency Disorders, Hurler Syndrome (MPS I), Krabbe Disease (Globoid Leukodystrophy), X-linked Adrenoleukodystrophy, Primary Immunodeficiency Diseases, Bone Marrow Failure, Beta-thalassemia
    Limit Computed Tomography (CT) Scanning in Suspected Renal Colic
    Yale University, Emergency Department
    New Haven, Connecticut 06519
    Renal Colic, Flank Pain, Back Pain
    Phase I Biomarker Study (BMS-936558)
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Renal Cell Carcinoma
    PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Lymphoma
    Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Metastatic Pancreatic Adenocarcinoma
    A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Non Small Cell Lung Cancer
    Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer
    Smilow Cancer Hospital at Yale New Haven
    New Haven, Connecticut 06510
    Endometrial Cancer
    Bortezomib and Sorafenib Tosylate in Patients With Newly Diagnosed Acute Myeloid Leukemia With or Without Mutations
    Yale University
    New Haven, Connecticut 06520
    Adult Acute Erythroid Leukemia (M6), Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Pure Erythroid Leukemia (M6b), Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Minimally Differentiated Myeloid Leukemia (M0), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloblastic Leukemia With Maturation (M2), Childhood Acute Myeloblastic Leukemia Without Maturation (M1), Childhood Acute Myelomonocytic Leukemia (M4), Untreated Adult Acute Myeloid Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
    A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
    Yale University School of Medicine Yale SC
    New Haven, Connecticut 06520
    Solid Tumors and Advanced Endometrial Cancer, Endometrial Cancer, Second-line Treatment, VEGF
    pCLE For the Diagnosis Of Cancer in Unknown Bile Duct Stricture
    Yale New Haven Hospital
    New Haven, Connecticut 06520
    Cholangiocarcinoma, Bile Duct Inflammation
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
    Yale University
    New Haven, Connecticut 06520
    B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, Cognitive/Functional Effects, Neurotoxicity, Pain, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Therapy-related Toxicity, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Evaluation of Trastuzumab In Patients With HER2 Positive Persistent Or Recurrent Vulvar Paget's Disease
    Smilow Cancer Hospital at Yale New Haven
    New Haven, Connecticut 06510
    Paget's Disease of the Vulva
    Safety, Tolerability and Efficacy Study of the Monoclonal Antibody, CT-011, in Patients With Metastatic Melanoma
    Yale University School of Medicine, Section of Med Onc.
    New Haven, Connecticut 06520
    Melanoma, Malignant Melanoma
    Biomarker Study of Elotuzumab in High Risk Smoldering Myeloma
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Smoldering Multiple Myeloma
    A Phase 1/2 Study of the Oral ALK/EGFR Inhibitor AP26113
    Yale University, Site #033
    New Haven, Connecticut 06520
    Advanced Malignancies, Carcinoma, Non-Small-Cell Lung, Anaplastic Large Cell Lymphoma, Diffuse Large Cell Lymphoma, Inflammatory Myofibroblastic Tumors
    A Randomized Controlled Trial of Routine Shave Margins Versus Standard Partial Mastectomy in Breast Cancer Patients
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Breast Cancer
    A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
    Yale University
    New Haven, Connecticut 06520
    Urologic Neoplasms, Metastatic Bladder Cancer, Urinary Tract Neoplasms
    Maintenance Therapy: Lenalidomide Following Bendamustine and Rituximab Induction Therapy for Chronic Lymphocytic Leukemia
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Chronic Lymphocytic Leukemia
    Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib
    Yale University School of Medicine/Yale Cancer Center
    New Haven, Connecticut 06520
    Breast Cancer, Breast Neoplasm
    Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Ulcerative Colitis
    Clinical and Biological Predictors of Chemotherapy Toxicity in Older Adults
    Yale University
    New Haven, Connecticut 06520
    Breast Cancer